Variant · Snv
MAP3K1 NM_005921.2(MAP3K1):c.2179+16T>G
CI-VAR-00071670Explore in graph →NM_005921.2:c.2179+16T>GClinVar 445450 rs201491763
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-14
- Retrieved
- Sep 15, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260915-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 445450 | Benign/Likely benign | criteria provided, multiple submitters, no conflicts | 2 | 46,XY sex reversal 6; Ovarian serous cystadenocarcinoma; Cholangiocarcinoma; Acute myeloid leukemia; Lung cancer; Cervical cancer; Uterine corpus endometrial carcinoma; Thymoma; Familial cancer of breast | germline | 3 | Oct 07, 2025 | clinvar |